Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Pascolo

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2008
Results of the first phase I/II clinical vaccination trial with direct injection of mRNABenjamin Weide, Jean-Philippe Carralot, Anne Reese, et al.
Viruses|July 2, 2021
Lipofection with Synthetic mRNA as a Simple Method for T-Cell ImmunomonitoringNatalia Teresa Jarzebska, Julia Frei, Severin Lauchli, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 13, 2005
Co-transfection of messenger RNA and siRNA as a method to study the efficiency of siRNAThorsten Mutzke, Gudrun Schubkegel, Regina Teufel, et al.
Acta Dermato-Venereologica|November 5, 2014
Disseminated Primary Cutaneous CD8+ Small/Medium-sized Pleomorphic T-cell Lymphoma Responding to HydroxychloroquineValerie C Amann, Jil Dreier, Desislava Ignatova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2015
Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic CellsJürgen Brück, Steve Pascolo, Kerstin Fuchs, et al.
Oncoimmunology|March 1, 2021
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndromeChristoph Iselin, Yun-Tsan Chang, Tanja Schlaepfer, et al.
Leukemia & Lymphoma|January 15, 2019
Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndromeFlorian Anzengruber, Desislava Ignatova, Tanja Schlaepfer, et al.
Genetic Vaccines and Therapy|August 24, 2005
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomasJean-Philippe Carralot, Benjamin Weide, Oliver Schoor, et al.
International Immunology|April 2, 2005
CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patientsJean-Philippe Carralot, Claudia Dumrese, Ralf Wessel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patientsBenjamin Weide, Steve Pascolo, Birgit Scheel, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2008
Results of the first phase I/II clinical vaccination trial with direct injection of mRNABenjamin Weide, Jean-Philippe Carralot, Anne Reese, et al.
Viruses|July 2, 2021
Lipofection with Synthetic mRNA as a Simple Method for T-Cell ImmunomonitoringNatalia Teresa Jarzebska, Julia Frei, Severin Lauchli, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 13, 2005
Co-transfection of messenger RNA and siRNA as a method to study the efficiency of siRNAThorsten Mutzke, Gudrun Schubkegel, Regina Teufel, et al.
Acta Dermato-Venereologica|November 5, 2014
Disseminated Primary Cutaneous CD8+ Small/Medium-sized Pleomorphic T-cell Lymphoma Responding to HydroxychloroquineValerie C Amann, Jil Dreier, Desislava Ignatova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2015
Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic CellsJürgen Brück, Steve Pascolo, Kerstin Fuchs, et al.
Oncoimmunology|March 1, 2021
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndromeChristoph Iselin, Yun-Tsan Chang, Tanja Schlaepfer, et al.
Leukemia & Lymphoma|January 15, 2019
Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndromeFlorian Anzengruber, Desislava Ignatova, Tanja Schlaepfer, et al.
Genetic Vaccines and Therapy|August 24, 2005
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomasJean-Philippe Carralot, Benjamin Weide, Oliver Schoor, et al.
International Immunology|April 2, 2005
CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patientsJean-Philippe Carralot, Claudia Dumrese, Ralf Wessel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patientsBenjamin Weide, Steve Pascolo, Birgit Scheel, et al.
Pageof 8